324
Participants
Start Date
November 30, 2006
Primary Completion Date
July 31, 2009
Study Completion Date
July 31, 2010
TAXUS® Liberté™
Drug eluting stent implantation stent in the treatment of coronary artery disease in participants with Diabetes
XIENCE V® EECSS
Drug eluting stent implantation stent in the treatment of coronary artery disease in participants with Diabetes
Salzburger Landeskliniken, Salzburg
C.H.U. - Hopital Michallon, Grenoble
CHU Lille - Hôpital Cardiologique, Lille
Herzzentrum, Bernau
Universitätsklinikum, Heidelberg
Lukas Krankenhaus Neuss, Neuss
Herzzentrum Siegburg GmbH, Siegburg
Sheba Medical Center, Ramat Gan
Azienda Ospedaliera Riuniti, Bergamo
Ospedale Civile, Mirano
Azienda Ospedaliera di Padova, Padua
IRCCS Policlinico San Matteo, Pavia
Azienda Ospedaliera S. Gdi Dio Salerno, Salerno
Institute Jantung Negara, Kuala Lumpur
Medisch Centrum Alkmaar, Alkmaar
Maasstad Ziekenhuis, Rotterdam
Medical University of Bydgoszcz, Bydgoszcz
General De Alicante, Alicante
Hospital Belvigte de Barcelona, Barcelona
Hospital Santa Creu I Sant Pau, Barcelona
Clinico San Carlos, Madrid
Hospital Puerta de Hierro, Madrid
La Paz, Madrid
Hospital Virgen de la Arrixaca, Murcia
Hospital General de Valencia, Valencia
King Chulalongkorn Memorial Hospital, Bangkok
King's College Hospital, London
Wessex Cardiac Unit, Southampton
Lead Sponsor
Abbott Medical Devices
INDUSTRY